These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39175365)

  • 1. Disability in migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study.
    Katsarava Z; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Adams AM; Carr K; Fanning KM; Lipton RB
    Cephalalgia; 2024 Aug; 44(8):3331024241274343. PubMed ID: 39175365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing neck pain during headache among people with migraine: Multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) cross-sectional study.
    Matharu M; Katsarava Z; Buse DC; Sommer K; Reed ML; Fanning KM; Lipton RB
    Headache; 2024; 64(7):750-763. PubMed ID: 38982663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and post-headache phases of migraine: multi-country results from the CaMEO - International Study.
    Lipton RB; Lanteri-Minet M; Leroux E; Manack Adams A; Contreras-De Lama J; Reed ML; Fanning KM; Buse DC
    J Headache Pain; 2023 Nov; 24(1):151. PubMed ID: 37940856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
    Buse DC; Sakai F; Matharu M; Reed ML; Fanning K; Dabruzzo B; Lipton RB
    Headache; 2024 May; 64(5):469-481. PubMed ID: 38706199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
    Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
    Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) study.
    Lanteri-Minet M; Leroux E; Katsarava Z; Lipton RB; Sakai F; Matharu M; Fanning K; Manack Adams A; Sommer K; Seminerio M; Buse DC
    J Headache Pain; 2024 Aug; 25(1):134. PubMed ID: 39160483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study and American Migraine Prevalence and Prevention (AMPP) Study: Demographics and Headache-Related Disability.
    Lipton RB; Manack Adams A; Buse DC; Fanning KM; Reed ML
    Headache; 2016 Sep; 56(8):1280-9. PubMed ID: 27349336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study.
    Lipton RB; Pozo-Rosich P; Orr SL; Reed ML; Fanning KM; Dabruzzo B; Buse DC
    Headache; 2023; 63(10):1448-1457. PubMed ID: 37795746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
    Adams AM; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Katsarava Z; Reed ML; Fanning K; Sommer K; Lipton RB
    Cephalalgia; 2023 Jun; 43(6):3331024231180611. PubMed ID: 37314231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuation of Acute Prescription Medication for Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Hutchinson S; Ailani J; Reed ML; Fanning KM; Manack Adams A; Buse DC
    Headache; 2019 Nov; 59(10):1762-1772. PubMed ID: 31544244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The unique role of stigma in migraine-related disability and quality of life.
    Seng EK; Shapiro RE; Buse DC; Robbins MS; Lipton RB; Parker A
    Headache; 2022 Nov; 62(10):1354-1364. PubMed ID: 36321956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
    Lipton RB; Seng EK; Chu MK; Reed ML; Fanning KM; Adams AM; Buse DC
    Headache; 2020 Sep; 60(8):1683-1696. PubMed ID: 33448374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study.
    Hirata K; Ueda K; Komori M; Zagar AJ; Selzler KJ; Nelson AM; Han Y; Jaffe DH; Matsumori Y; Takeshima T
    Curr Med Res Opin; 2021 Nov; 37(11):1945-1955. PubMed ID: 34429000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.
    Ford JH; Ye W; Ayer DW; Mi X; Bhandari S; Buse DC; Lipton RB
    J Patient Rep Outcomes; 2023 Apr; 7(1):34. PubMed ID: 37016181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photophobia Contributes to Migraine-Associated Disability and Reduced Work Productivity: Results From the American Registry for Migraine Research (ARMR).
    Leibovit-Reiben Z; Dumkrieger G; Dodick DW; Digre K; Chong CD; Trivedi M; Schwedt TJ
    J Neuroophthalmol; 2024 Jun; 44(2):259-266. PubMed ID: 37581595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
    Ford JH; Kurth T; Starling AJ; Ayer DW; Wietecha LA; Port MD; Rettiganti M; Ruff DD
    Headache; 2020 Nov; 60(10):2304-2319. PubMed ID: 33249580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.
    Matsumori Y; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Takeshima T; Hirata K
    Neurol Ther; 2022 Mar; 11(1):205-222. PubMed ID: 34862581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study.
    Young WB; Ivan Lopez J; Rothrock JF; Orejudos A; Manack Adams A; Lipton RB; Blumenfeld AM
    J Headache Pain; 2019 Jan; 20(1):10. PubMed ID: 30669961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study.
    Buse DC; Powers SW; Gelfand AA; VanderPluym JH; Fanning KM; Reed ML; Adams AM; Lipton RB
    Headache; 2018 Apr; 58(4):512-524. PubMed ID: 29355924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO Study.
    Hutchinson S; Lipton RB; Ailani J; Reed ML; Fanning KM; Adams AM; Buse DC
    Mayo Clin Proc; 2020 Apr; 95(4):709-718. PubMed ID: 32247344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.